Opthea Limited Unsponsored ADR (NASDAQ:OPT - Get Free Report) traded up 7.2% during mid-day trading on Friday . The stock traded as high as $3.48 and last traded at $3.41. 3,000 shares changed hands during trading, The stock had previously closed at $3.18.
Opthea Trading Up 7.2%
The firm has a 50-day simple moving average of $3.41 and a 200-day simple moving average of $3.77.
Institutional Trading of Opthea
A number of institutional investors have recently made changes to their positions in OPT. EP Wealth Advisors LLC purchased a new position in Opthea in the 1st quarter worth $34,000. OLD Mission Capital LLC purchased a new position in shares of Opthea during the 4th quarter valued at about $42,000. Citadel Advisors LLC purchased a new position in shares of Opthea during the 4th quarter valued at about $79,000. Twin Lakes Capital Management LLC raised its stake in shares of Opthea by 67.4% during the 1st quarter. Twin Lakes Capital Management LLC now owns 33,156 shares of the company's stock valued at $113,000 after buying an additional 13,350 shares during the last quarter. Finally, Hsbc Holdings PLC purchased a new position in shares of Opthea during the 4th quarter valued at about $556,000. Institutional investors and hedge funds own 55.95% of the company's stock.
Opthea Company Profile
(
Get Free Report)
Opthea Limited, a clinical stage biopharmaceutical company, engages in the development and commercialization of therapies primarily for eye disease in Australia. The company's development activities are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors (VEGF) VEGF-C, VEGF-D, and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage.
Featured Articles
Before you consider Opthea, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Opthea wasn't on the list.
While Opthea currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access